Mebendazole monotherapy and long-term disease control in metastatic adrenocortical carcinoma
The FDA added a boxed warning to tirzepatide in June 2024, spotlighting severe gastroparesis risk but noting benefits outweigh harms
However, some individuals might experience mild gastrointestinal side effects, such as nausea, bloating, or diarrhea, especially as their body adapts to the medication
Routine blood work, blood sugar checks, and regular conversations about diet help catch these issues early while obesity treatment continues
However, individual patient reports of UTIs whilst taking Wegovy do exist, which may reflect several factors
The primary treatment consists in regular injections of growth hormone, but because of needle pain and the considerable expense, researchers began to look for other ways to boost the levels of growth hormone in these children